AU2018360532A1 - Material for pearl culturing and coating composition - Google Patents
Material for pearl culturing and coating composition Download PDFInfo
- Publication number
- AU2018360532A1 AU2018360532A1 AU2018360532A AU2018360532A AU2018360532A1 AU 2018360532 A1 AU2018360532 A1 AU 2018360532A1 AU 2018360532 A AU2018360532 A AU 2018360532A AU 2018360532 A AU2018360532 A AU 2018360532A AU 2018360532 A1 AU2018360532 A1 AU 2018360532A1
- Authority
- AU
- Australia
- Prior art keywords
- pearl
- protein
- collagen
- nucleus
- present disclosure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000463 material Substances 0.000 title claims abstract description 29
- 239000008199 coating composition Substances 0.000 title claims abstract description 25
- 238000012258 culturing Methods 0.000 title abstract description 4
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 111
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 109
- 150000001413 amino acids Chemical class 0.000 claims abstract description 44
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 44
- 102000008186 Collagen Human genes 0.000 claims description 41
- 108010035532 Collagen Proteins 0.000 claims description 41
- 229920001436 collagen Polymers 0.000 claims description 39
- 238000000576 coating method Methods 0.000 claims description 35
- 239000011248 coating agent Substances 0.000 claims description 31
- 108010022452 Collagen Type I Proteins 0.000 claims description 12
- 102000012422 Collagen Type I Human genes 0.000 claims description 12
- 238000005227 gel permeation chromatography Methods 0.000 claims description 11
- 230000003252 repetitive effect Effects 0.000 abstract 1
- 239000011049 pearl Substances 0.000 description 131
- 235000018102 proteins Nutrition 0.000 description 103
- 235000001014 amino acid Nutrition 0.000 description 43
- 238000003780 insertion Methods 0.000 description 31
- 230000037431 insertion Effects 0.000 description 31
- 230000000052 comparative effect Effects 0.000 description 28
- 108090000765 processed proteins & peptides Proteins 0.000 description 28
- 239000007788 liquid Substances 0.000 description 26
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical group NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 22
- 241000490567 Pinctada Species 0.000 description 21
- 238000011156 evaluation Methods 0.000 description 15
- 238000000034 method Methods 0.000 description 12
- 229920001184 polypeptide Polymers 0.000 description 12
- 102000004196 processed proteins & peptides Human genes 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 108010010803 Gelatin Proteins 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 239000008273 gelatin Substances 0.000 description 11
- 229920000159 gelatin Polymers 0.000 description 11
- 235000019322 gelatine Nutrition 0.000 description 11
- 235000011852 gelatine desserts Nutrition 0.000 description 11
- 239000000126 substance Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 230000003115 biocidal effect Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 108010022514 Collagen Type V Proteins 0.000 description 5
- 102000012432 Collagen Type V Human genes 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000021164 cell adhesion Effects 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- 235000015170 shellfish Nutrition 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 210000002919 epithelial cell Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
- 239000007995 HEPES buffer Substances 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 230000009878 intermolecular interaction Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 241000237536 Mytilus edulis Species 0.000 description 2
- 241001212699 Pinctada martensii Species 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 235000020638 mussel Nutrition 0.000 description 2
- -1 organic acid salt Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001122126 Carex secta Species 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010069502 Collagen Type III Proteins 0.000 description 1
- 102000001187 Collagen Type III Human genes 0.000 description 1
- 108010042086 Collagen Type IV Proteins 0.000 description 1
- 102000004266 Collagen Type IV Human genes 0.000 description 1
- 108010017377 Collagen Type VII Proteins 0.000 description 1
- 102000004510 Collagen Type VII Human genes 0.000 description 1
- 108010001463 Collagen Type XVIII Proteins 0.000 description 1
- 102000047200 Collagen Type XVIII Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000385229 Fusconaia flava Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 241000382833 Lamprotula Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000899871 Reginaia ebena Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 108010031318 Vitronectin Proteins 0.000 description 1
- 102100035140 Vitronectin Human genes 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 150000001782 cephems Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 108010044493 collagen type XVII Proteins 0.000 description 1
- 108010062101 collagen type XXI Proteins 0.000 description 1
- 108010044759 collagen type XXIV Proteins 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000010984 cultured pearl Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 239000011257 shell material Substances 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/50—Culture of aquatic animals of shellfish
- A01K61/54—Culture of aquatic animals of shellfish of bivalves, e.g. oysters or mussels
- A01K61/56—Culture of aquatic animals of shellfish of bivalves, e.g. oysters or mussels for pearl production
- A01K61/57—Pearl seeds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/50—Culture of aquatic animals of shellfish
- A01K61/54—Culture of aquatic animals of shellfish of bivalves, e.g. oysters or mussels
- A01K61/56—Culture of aquatic animals of shellfish of bivalves, e.g. oysters or mussels for pearl production
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D189/00—Coating compositions based on proteins; Coating compositions based on derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D189/00—Coating compositions based on proteins; Coating compositions based on derivatives thereof
- C09D189/04—Products derived from waste materials, e.g. horn, hoof or hair
- C09D189/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Marine Sciences & Fisheries (AREA)
- Biodiversity & Conservation Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Peptides Or Proteins (AREA)
- Farming Of Fish And Shellfish (AREA)
Abstract
Provided are: a material for pearl culturing in which at least one selected from the group consisting of a pearl core and pallium piece includes a repetitive sequence of GXY triplet which may be separated with one or more amino acids, and one or more RGD motifs, wherein the material for pearl culturing is covered with a protein having a polydispersity of less than 20; and a coating composition including the protein.
Description
PEARL CULTURE MATERIAL AND COATING COMPOSITION
BACKGROUND OF THE INVENTION
1. Field of the Invention [0001] The present disclosure relates to a pearl culture material and a coating composition.
2. Description of the Related Art [0002] Pearls can be produced by inserting a small piece of mantle and a pearl nucleus into a body of a mother pearl oyster which is capable of producing pearls, and allowing to secrete a nacreous substance on a surface of the pearl nucleus. Various techniques have been proposed for the purpose of obtaining a high quality pearl.
For example, there has been disclosed a mother nucleus for cultured pearls, characterized in that a surface of a sphere mainly composed of plastic having a specific gravity of 2.3 to 2.7 and having a small amount of eluted material is coated with a film mainly composed of insolubilized collagen (see, for example, JP1975-075997U (JP-S50-075997U)).
In addition, there has been disclosed a nucleus for pearl culture, characterized in that the surface of a nucleus for culture is coated with a cell-scaffolding organic substance that is nontoxic to pearl oysters and is less rejective than calcium crystals (see, for example, JP1989-148135A(JP-H01-148135A)).
In addition, as a cell activator for pearl culture which is used for treating a mantle section of a mother pearl oyster for pearl culture, there has been disclosed a mantle cell activator for pearl culture, characterized by containing an artificial polypeptide which has an Arg-Gly-Asp sequence in a molecule thereof and has a cell adhesion activity and a cell activation activity (see, for example, JP1993-236848A(JP-H05-236848A)).
In addition, there has been disclosed a method for treating a pearl nucleus, characterized by treating a mantle section used for an inserted nucleus with naturally occurring vitronectin (see, for example, JP1995-132032A (JP-H07-132032A)).
In addition, there has been disclosed a pearl nucleus characterized in that the surface of the nucleus has a positive charge (see, for example, WO2015/033972A).
In addition, there has been disclosed a method for culturing pearls in which a piece obtained from the mantle of a piece shellfish and a pearl nucleus are transplanted into a mother pearl oyster to culture pearls, characterized by separating epithelial cells from an epithelial tissue of the mantle as the piece, and using the separated epithelial cells artificially cultured in vitro (see, for example, JP2006-304628A).
12316751_1 (GHMatters) P113238.AU
SUMMARY OF THE INVENTION [0003] However, irrespective of the existence of JP1975-075997U (JP-S50-075997U), JP1989-148135A (JP-H01-148135A), JP1993-236848A (JP-H05-236848A), JP1995-132032A (JP-H07-132032A), WO2015/033972A, and JP2006-304628A, a yield of a high quality pearl cannot be said to be sufficiently high, and there is still a problem of improving the yield of the high quality pearl.
[0004] In addition, in a case of producing pearls, it is necessary to insert a mantle piece (a small piece of the mantle) and a pearl nucleus into the body of a mother pearl oyster which is capable of producing pearls (nucleus insertion), but a protein that coats the pearl nucleus or mantle piece, described in JP1975-075997U (JP-S50-075997U), JP1989-148135A (JP-H01-148135A), JP1993-236848A (JP-H05-236848A), JP1995-132032A (JP-H07-132032A), and WO2015/033972A, has a problem in that, since the protein has high adhesiveness, the operability at the time of nucleus insertion into the mother pearl oyster is poor and therefore the efficiency of the nucleus insertion operation is reduced.
[0005] In view of the above, an object to be achieved by one embodiment of the present invention is to provide a pearl culture material that improves a yield of a high quality pearl and is excellent in the operability of nucleus insertion into a mother pearl oyster and a coating composition for producing a pearl culture material.
[0006] Specific means for achieving the foregoing object include the following aspects.
<1> A pearl culture material in which at least one selected from the group consisting of a pearl nucleus and a mantle piece is coated with a protein containing a repeating sequence of GXY triplets which may be separated by one or more amino acids, and one or more RGD motifs, and having a polydispersity of less than 20.
<2> The pearl culture material according to <1>, in which the protein has a weight-average molecular weight of 30 kDa to 200 kDa determined by gel permeation chromato graphy.
<3> The pearl culture material according to <1> or <2>, in which the protein comprises at least a part of an amino acid sequence of collagen.
<4> The pearl culture material according to <3>, in which the amino acid sequence of the collagen is an amino acid sequence of type I collagen al chain.
<5> A coating composition for coating at least one selected from a pearl nucleus or a mantle piece, comprising:
a protein containing a repeating sequence of GXY triplets which may be separated by
12316751_1 (GHMatters) P113238.AU one or more amino acids, and one or more RGD motifs, and having a polydispersity of less than 20.
[0007] According to the present disclosure, there are provided a pearl culture material that improves a yield of a high quality pearl and is excellent in the operability of nucleus insertion into a mother pearl oyster and a coating composition for producing a pearl culture material.
DESCRIPTION OF THE PREFERRED EMBODIMENTS [0008] In the present disclosure, a numerical range indicated using “to” means a range including numerical values described before and after “to” as a minimum value and a maximum value, respectively. In a numerical range described in a stepwise manner in the present disclosure, an upper limit value or a lower limit value described in a certain numerical range may be replaced with an upper limit value or a lower limit value of another numerical range described in a stepwise manner. In addition, in the numerical range described in the present disclosure, the upper limit value or the lower limit value described in a certain numerical range may be replaced with the values shown in the Examples.
[0009] In the present disclosure, in a case where a plurality of substances corresponding to components are present in the composition, the amount of each component in the composition means a total amount of the plurality of substances present in the composition, unless otherwise noted.
[0010] In the present disclosure, the term “peptide” refers to a generic term for compounds formed by binding two or more amino acids through peptide bonds.
In the present disclosure, the term “polypeptide” refers to a generic term for compounds formed by peptide bonding of 10 or more amino acids. In a case where the number of amino acids is 10 or more, the “peptide” and the “polypeptide” can be used interchangeably.
In the present disclosure, the term “protein” refers to a polypeptide having a molecular weight of 5000 or more. In a case where the molecular weight is 5000 or more, the “protein” and the “polypeptide” can be used interchangeably.
In the present disclosure, the weight-average molecular weight (Mw) and the number-average molecular weight (Mn) of a protein are expressed in units of dalton (Da).
In the present disclosure, the term “pearl nucleus” refers to a material in which a pearl layer made of a nacreous substance mainly composed of calcium carbonate secreted from epithelial cells of the mantle is formed on the surface thereof by being inserted into a pearl oyster together with a mantle piece. The size of the pearl nucleus may be appropriately
12316751_1 (GHMatters) P113238.AU selected according to a desired size of the pearl, and the pearl nucleus is, for example, a spherical material of 4 mm to 10 mm. The material for the pearl nucleus is typically a shell material of a freshwater bivalve, and examples of the freshwater bivalve include the genus Lamprotula, pig-toe mussel (Fusconaia flava), and niggerhead mussel (Fusconaia ebenus).
In the present disclosure, the term “mantle piece” refers to a small piece of mantle of a shellfish which is inserted into a pearl oyster together with a pearl nucleus to thereby secrete a nacreous substance mainly composed of calcium carbonate from the epithelial cells of the mantle contained in the mantle piece, thus resulting in the formation of a pearl layer on the surface of the pearl nucleus. Shellfish used for producing the mantle piece include Pinctada fucata martensii and the like. The size of the mantle piece may be appropriately selected according to the size of the pearl nucleus and is, for example, about 2 mm to 4 mm square. [0011] In the present disclosure, the weight-average molecular weight and the number-average molecular weight of a protein are values determined as pullulan-converted molecular weights measured by gel permeation chromatography using a GPC apparatus (HLC-8220GPC, manufactured by Tosoh Corporation) under the following conditions. An aqueous solution of a protein to be measured (after thawing for a frozen preparation) is heated at 40°C for 30 minutes to completely dissolve the protein, diluted with 100 mM phosphate buffer such that the concentration of the protein to be measured is 0.2% by mass, and then filtered through a 0.45 pm filter to prepare a sample solution. This sample solution is measured using the above-mentioned GPC apparatus to obtain a weight-average molecular weight and a number-average molecular weight.
[GPC measurement conditions]
Column: Shodex Asahipak GS-620 7G-P, inner diameter: 7.5 mm, length: 50 cm (manufactured by Showa Denko K.K.)
Eluent: 100 mM phosphate buffer (pH = 6.9)
Flow rate: sample: 1.0 mL/min, reference: 0.1 mL/min
Column temperature (setting): 40°C
Injection volume: 100 pL
Detector: RI/UV (210 nm)
Protein for molecular weight calibration: pullulan (Shodex P-82, manufactured by Showa Denko K.K.) [0012] In the present disclosure, the term “tackiness” means “adhesiveness” or “stickiness” used in relation to the workability in a case of carrying out insertion of a pearl culture material.
12316751_1 (GHMatters) P113238.AU [0013] <Pearl culture material>
In the pearl culture material of the present disclosure, at least one selected from the group consisting of a pearl nucleus and a mantle piece is coated with a protein containing a repeating sequence of GXY triplets which may be separated by one or more amino acids, and one or more RGD motifs, and having a polydispersity of less than 20.
Pearls can be produced by inserting a mantle piece and a pearl nucleus into a body of a mother pearl oyster which is capable of producing pearls, and allowing to secrete a nacreous substance on a surface of the nucleus. Various techniques have been proposed for the purpose of obtaining a high quality pearl, but the yield of the high quality pearl is not sufficiently high.
In addition, in a case of producing pearls, it is necessary to insert the mantle piece and the pearl nucleus into the body of a mother pearl oyster which is capable of producing pearls. In this regard, although the related art discloses mantle pieces or pearl nuclei coated with specific proteins or polypeptides, these proteins or polypeptides that coat the mantle pieces or pearl nuclei have high adhesiveness, which results in poor operability at the time of nucleus insertion into a mother pearl oyster and therefore reduced working efficiency.
On the other hand, according to the present disclosure, it is possible to provide a pearl culture material that improves a yield of a high quality pearl and is excellent in the operability of nucleus insertion into a mother pearl oyster. The reason for providing such an effect is not clear, but it is speculated as follows. That is, it is considered that the protein of the present disclosure, which coats at least one selected from the group consisting of a pearl nucleus and a mantle piece, contains one or more RGD motifs involved in cell adhesion, and as a result, the extension of mantle cells to the surface of the pearl nucleus after the nucleus insertion is promoted, and thus a high quality pearl with few stains is generated. In addition, it is considered that the protein of the present disclosure, which coats at least one selected from the group consisting of a pearl nucleus and a mantle piece, contains a repeating sequence of GXY triplets which may be separated by one or more amino acids, thereby having a structure similar to a collagen protein having high biocompatibility, and in a case where at least one selected from the group consisting of a pearl nucleus and a mantle piece, each of which is coated with the protein, is inserted, the yield of a high quality pearl is improved. In addition, it is considered that, since the protein which coats at least one selected from the group consisting of a pearl nucleus and a mantle piece has a polydispersity of less than 20 and is a highly unity macromolecule, the interaction between the pearl nucleus and the mantle tissue in a mother
12316751_1 (GHMatters) P113238.AU pearl oyster at a biological tissue level can be equalized, whereby the effect of improving the yield of a good quality pearl can be exhibited. In addition, it is considered that, since the protein which coats at least one selected from the group consisting of a pearl nucleus and a mantle piece has a polydispersity of less than 20 and is a highly unity macromolecule, the bonds between polar hydrophilic groups between protein molecules are formed preferentially over the bonds due to intermolecular interaction between polar hydrophilic groups and water molecules, and as a result, moisture absorption due to moisture in the air, which is a main cause of tackiness, (that is, the intermolecular interaction with water) is inhibited, and therefore the operability at the time of nucleus insertion is improved.
[0014] (Protein)
The protein of the present disclosure contains a repeating sequence of GXY triplets which may be separated by one or more amino acids, and one or more RGD motifs, and has a polydispersity of less than 20.
[0015] The weight-average molecular weight of the protein of the present disclosure is preferably 30 kDa (kilodalton) to 200 kDa, more preferably 30 kDa to 100 kDa, still more preferably 40 kDa to 75 kDa, and most preferably 50 kDa to 60 kDa. In a case where the weight-average molecular weight of the protein of the present disclosure is within the above range, deliquescence due to excessive moisture absorption is suppressed while the protein has good solubility in water.
[0016] The number-average molecular weight of the protein of the present disclosure is preferably 15 kDa to 100 kDa, more preferably 20 kDa to 80 kDa, still more preferably 30 kDa to 60 kDa, and most preferably 40 kDa to 50 kDa. In a case where the number-average molecular weight of the protein of the present disclosure is within the above range, deliquescence due to excessive moisture absorption is suppressed while the protein has good solubility in water.
[0017] - Polydispersity In the present disclosure, the polydispersity of a protein is a value (Mw/Mn) obtained by dividing a weight-average molecular weight (Mw) by a number-average molecular weight (Mn).
The protein has a polydispersity of less than 20, preferably a polydispersity of less than 10, more preferably a polydispersity of less than 5, and still more preferably a poly dispersity of less than 2. It is considered that, in a case where the poly dispersity of the protein of the present disclosure is in the above range, the interaction between the pearl
12316751_1 (GHMatters) P113238.AU nucleus and the mantle tissue in a mother pearl oyster at a biological tissue level can be equalized, whereby the effect of improving the yield of a good quality pearl can be exhibited. In addition, it is considered that the bonds between polar hydrophilic groups between protein molecules are formed preferentially over the bonds due to intermolecular interaction between polar hydrophilic groups and water molecules, and as a result, moisture absorption due to moisture in the air, which is a main cause of tackiness, is inhibited, and therefore the operability at the time of nucleus insertion is excellent.
[0018] -GXY triplet In the present disclosure, the term “GXY triplet” refers to a unit of an amino acid sequence in which three amino acids “G (glycine)”, “X (any amino acid other than G)”, and “Y (any amino acid other than G)” are present from an N-terminal side to a C-terminal side, where X and Y are each independently any amino acid other than G. “X” or “Y” tends to be “P (proline)” or “4-hydroxyproline”.
The percentage (total percentage) of the region occupied by the GXY triplets to the entire amino acid sequence of the protein of the present disclosure is preferably 50% or more, more preferably 60% or more, still more preferably 70% or more, even more preferably 80% or more, even still more preferably 90% or more, and particularly preferably 95% or more, based on the number of amino acid residues. In addition, the GXY triplet may be repeated over the entire length of the amino acid sequence of the protein of the present disclosure.
Due to the presence of the GXY triplet, the protein of the present disclosure has a structure similar to a collagen protein having high biocompatibility. For this reason, it is considered that the yield of a high quality pearl is improved in a case where at least one selected from the group consisting of a pearl nucleus and a mantle piece, each of which is coated with the protein, is inserted.
[0019] In the present disclosure, “GXY triplets” may be connected in series without including an amino acid between the GXY triplets, and one or more amino acids (amino acid residues) may be included between the GXY triplets. Preferably, GXY triplets are connected in series without including an amino acid between the GXY triplets.
[0020] - RGD motif In the present disclosure, the term “RGD motif’ refers to a motif in which three amino acids “R (arginine)”, “G (glycine)”, and “D (aspartic acid)” are present from an N-terminal side to a C-terminal side. It is considered that, since the “RGD motif’ is involved in cell adhesion, a pearl culture material having the protein of the present disclosure on the
12316751_1 (GHMatters) P113238.AU surface of a pearl nucleus or mantle piece is inserted to thereby promote the extension of mantle cells to the surface of the pearl nucleus, resulting in the generation of a high quality pearl with few stains.
The term motif used in relation to a protein refers to an amino acid sequence having a functional or structural characteristic.
[0021] In the protein of the present disclosure, the number of “RGD motifs” may be 1 to 100, preferably 5 to 75, more preferably 10 to 50, and still more preferably 10 to 25.
In addition, the “RGD motif’ is preferably contained at a ratio of 1 to 10 to 100 constituent amino acids of the protein of the present disclosure, more preferably at a ratio of 1 to 20 to 75 constituent amino acids of the protein of the present disclosure, still more preferably at a ratio of 1 to 30 to 60 constituent amino acids of the protein of the present disclosure, and most preferably at a ratio of 1 to 45 to 55 constituent amino acids of the protein of the present disclosure.
In a case where the RGD motif is contained in the protein of the present disclosure in the above range, a cell adhesion promoting ability is in a preferable range, which can contribute to the production of a high quality pearl.
[0022] The “GXY triplet” and the “RGD motif’ can exist in an overlapping manner. That is, the first G of the GXY triplet may be the second G of the RGD motif.
[0023] The protein of the present disclosure preferably includes at least a portion of the amino acid sequence of collagen. More preferably, the protein of the present disclosure includes the amino acid sequence of a collagen domain of collagen (that is, a domain that forms a triple-stranded helix). Here, the collagen domain includes a repeating sequence of GXY triplets which may be separated by one or more amino acids, and one or more RGD motifs.
The percentage (total percentage) of the region occupied by the region derived from the amino acid sequence of collagen (for example, the amino acid sequence of SEQ ID NO: 1) to the entire amino acid sequence of the protein of the present disclosure is preferably 50% or more, more preferably 60% or more, still more preferably 70% or more, even more preferably 80% or more, even still more preferably 90% or more, and particularly preferably 95% or more.
The collagen may be from any species. The collagen is preferably of bovine, porcine, or human origin and more preferably of human origin.
[0024] The collagen can be any type of collagen. Examples of the collagen include type I collagen, type II collagen, type III collagen, type IV collagen, type V collagen, type VI
12316751_1 (GHMatters) P113238.AU collagen, type VII collagen, type VIII collagen, type IX collagen, type X collagen, type XI collagen, type XII collagen, type XIII collagen, type XIV collagen, type XV collagen, type XVI collagen, type XVII collagen, type XVIII collagen, type XIX collagen, type XX collagen, type XXI collagen, type XXII collagen, type XXIII collagen, type XXIV collagen, type XXV collagen, type XXVI collagen, type XXVII collagen, and type XXVIII collagen.
The amino acid sequence of the collagen, if present, may be an amino acid sequence of any subtype of a plurality of polypeptides constituting the collagen. For example, in a case of type I collagen, the amino acid sequence of the collagen may be the amino acid sequence of type I collagen al chain or the amino acid sequence of type I collagen a2 chain; and in a case of type V collagen, the amino acid sequence of the collagen may be the amino acid sequence of type V collagen al chain, the amino acid sequence of type V collagen a2 chain, or the amino acid sequence of type V collagen a3 chain.
In the present disclosure, the amino acid sequence of the collagen is preferably the amino acid sequence of type I collagen, and more preferably the amino acid sequence of type I collagen al chain.
[0025] The protein is preferably a polypeptide including the amino acid sequence of SEQ ID NO: 1 and more preferably a polypeptide made up of the amino acid sequence of SEQ ID NO:
1.
[0026] The protein that coats at least one selected from the group consisting of a pearl nucleus and a mantle piece may be a single polypeptide or a combination of two or more polypeptides. [0027] Collagen is contained in cow skin, pig skin, fish skin, or the like, but is insoluble in commonly used solvents such as water. For this reason, in a case where it is attempted to extract collagen, protein hydrolase is used or gelatinization is carried out by heating, which results in the generation of protein molecules having a wide range of molecular weights. For example, commercially available gelatin usually has a molecular weight distribution of tens of thousands to millions. Therefore, even in a case where naturally occurring collagen is extracted by a general method, the polydispersity is not less than 20.
[0028] In one embodiment, the protein of the present disclosure can be obtained by subjecting collagen extracted from a natural collagen source, such as cow skin, pig skin, or fish skin, to a fractionation method such as size exclusion chromatography to separate and purify only protein molecules within a specific molecular weight range. In another embodiment, the protein of the present disclosure can be obtained through the production by a recombinant cell into which a gene of a protein containing a repeating sequence of GXY triplets and containing
12316751_1 (GHMatters) P113238.AU one or more RGD motifs has been introduced. In this case, a bacterial cell such as Escherichia coli, a yeast cell such as S. Cervisiae, or an insect cell such as silkworm can be used as a host cell for introducing the protein gene. As an expression vector, an appropriate vector may be selected from known vectors and used depending on the host and the size of the protein to be introduced. In a case where the protein of the present disclosure is produced by a recombinant cell, a protein having high molecular weight uniformity can be obtained.
[0029] The amino acid sequence of human type I collagen al chain set forth in SEQ ID NO: 2 contains only two RGD sequences (a sequence of amino acids at positions 745 to 747 and a sequence of amino acids at positions 1093 to 1095) in the total length of 1464 amino acids. In a case where a protein prepared based on the amino acid sequence of human type I collagen al chain is used as the protein of the present disclosure, a protein having a more preferable cell adhesion promoting ability is obtained by changing the number of RGD sequences to the preferable range described above. In addition, it is considered that the removal of telopeptides present at both ends of the molecule and contributing to the association between collagen molecules results in the suppression of association between the molecules and the further improved workability at the time of nucleus insertion. In consideration of the above points, the protein of the present disclosure may be, for example, a protein including a plurality of (preferably 4 to 20, and more preferably 6 to 16) regions having a length of 20 amino acids to 60 amino acids including Arg at position 745 to Asp at position 747 in the amino acid of SEQ ID NO: 2. In this case, the plurality of regions each may be the same or different (in other words, the regions around the RGD at positions 745 to 747 overlap but the boundary points are different) and may be in direct contact with each other or one or more other amino acid residues may be interposed therebetween. Each of the regions is preferably a region having a length of 34 amino acids to 50 amino acids including a region of Gly at position 722 to Gly at position 755 independently of each other. In addition, the total amino acid length is preferably 200 amino acids to 800 amino acids and more preferably 300 amino acids to 600 amino acids, from the viewpoint of expression efficiency in recombinant cells, solubility in water, and suppression of deliquescence.
[0030] More specifically, the protein of the present disclosure may be a protein set forth in SEQ ID NO: 1. This protein is a 571 amino acid long protein including 12 regions of about several tens of amino acids including Arg at position 745 to Asp at position 747 in SEQ ID NO: 2. Alternatively, the protein of the present disclosure may be a protein having the amino acid sequence set forth in SEQ ID NO: 3 or a protein having an amino acid sequence in which
12316751_1 (GHMatters) P113238.AU the amino acid sequence set forth in SEQ ID NO: 3 is repeated a plurality of times (for example, 2, 3, 4, 5, or 6 times). In addition, the protein of the present disclosure may be a protein having an amino acid sequence having 90% or more (or 95% or more) sequence identity to any of these amino acid sequences, and in this case, it is preferable that each RGD motif in the original amino acid sequence is maintained. The amino acid sequence of SEQ ID NO: 3 corresponds to the region from the amino acid at position 4 to the amino acid at position 192 of the amino acid sequence of SEQ ID NO: 1.
[0031] The pearl culture material of the present disclosure includes a pearl nucleus coated with the protein of the present disclosure or a mantle piece coated with the protein of the present disclosure, or both. Thus, for example, an embodiment in which a pearl nucleus coated with the protein of the present disclosure is used with an uncoated mantle piece, and an embodiment in which a mantle piece coated with the protein of the present disclosure is used with an uncoated pearl nucleus are also included in the scope of the present disclosure.
[0032] In a case where the pearl nucleus is coated with the protein of the present disclosure, it is sufficient that at least a part of the surface of the pearl nucleus is coated. On the surface of the pearl nucleus coated with the protein of the present disclosure, the percentage of the area coated with the protein of the present disclosure to the total surface area of the pearl nucleus is preferably 20% or more, more preferably 30% or more, still more preferably 40% or more, even more preferably 50% or more, even still more preferably 60% or more, and particularly preferably 65% or more. The entire surface of the pearl nucleus may be coated with the protein of the present disclosure. The amount of the protein of the present disclosure coated on the pearl nucleus surface is not particularly limited, but may be, for example, 0.001 g/m2 to 100 g/m2, and more specifically, 0.05 g/m2 to 30 g/m2.
Similarly, in a case where the mantle piece is coated with the protein of the present disclosure, it is sufficient that at least a part of the surface of the mantle piece is coated. On the surface of the mantle piece coated with the protein of the present disclosure, the percentage of the area coated with the protein of the present disclosure to the total surface area of the mantle piece is preferably 20% or more, more preferably 30% or more, still more preferably 40% or more, even more preferably 50% or more, even still more preferably 60% or more, and particularly preferably 65% or more. The entire surface of the mantle piece may be coated with the protein of the present disclosure. The amount of the protein of the present disclosure coated on the surface of the mantle piece is not particularly limited, but may be, for example, 0.001 g/m2 to 100 g/m2, and more specifically, 0.05 g/m2 to 30 g/m2.
12316751_1 (GHMatters) P113238.AU [0033] In order to coat the pearl nucleus with the protein of the present disclosure, the protein of the present disclosure may be added to water and stirred to prepare a coating liquid, and the pearl nucleus may be coated with the coating liquid using a coating method known in the art. Examples of the coating method include a method of immersing the pearl nucleus in the coating liquid, a method of spraying the coating liquid on the pearl nucleus, and a method of coating the pearl nucleus with the coating liquid by a brush. The concentration of the protein of the present disclosure in the coating liquid is, for example, 0.0001% by mass to 1% by mass, and may be 0.0005% by mass to 0.5% by mass.
[0034] A salt such as NaCI or a buffer such as HEPES or PBS may coexist in the coating liquid, but it is preferable that the coating liquid is free of a substance harmful to the living body such as an organic solvent, from the viewpoint of avoiding adverse effects on the pearl oyster. The coating liquid may be a liquid coating composition itself among the coating compositions described later, or may be a solid coating composition or a liquid prepared by dissolving a freeze-dried product described later in a dissolution solution described later.
[0035] In order to coat the mantle piece with the protein of the present disclosure, the protein of the present disclosure may be added to water and stirred to prepare a coating liquid, and the mantle piece may be coated with the coating liquid using a coating method known in the art. Alternatively, the coating liquid may be coated on the mantle which may be then cut to prepare a mantle piece. Examples of the coating method include a method of immersing the mantle piece or the mantle in the coating liquid, a method of spraying the coating liquid on the mantle piece or the mantle, and a method of coating the mantle piece or the mantle with the coating liquid by a brush. The concentration of the protein of the present disclosure in the coating liquid is, for example, 0.0001% by mass to 1% by mass, and may be 0.0005% by mass to 0.5% by mass.
[0036] In a case of coating the mantle piece, a salt such as NaCI or a buffer such as HEPES or PBS may coexist in the coating liquid, but it is preferable that the coating liquid is free of a substance harmful to the living body such as an organic solvent, from the viewpoint of avoiding adverse effects on the pearl oyster. The coating liquid may be a liquid coating composition itself among the coating compositions described later, or may be a solid coating composition or a liquid prepared by dissolving a freeze-dried product described later in a dissolution solution described later.
[0037] <Coating composition>
In accordance with the foregoing, the present disclosure also provides a coating
12316751_1 (GHMatters) P113238.AU composition for coating at least one selected from a pearl nucleus or a mantle piece. The coating composition contains a protein of the present disclosure. The coating composition preferably further contains at least one selected from an excipient, a carrier, or the like that is suitable and does not adversely affect a mother pearl oyster. The coating composition may be liquid or solid. Examples of the suitable liquid carrier include water, an alcohol, an animal or vegetable oil such as soybean oil or olive oil, a mineral oil, and a synthetic oil. Examples of the suitable solid carrier include a sugar such as maltose or sucrose, an amino acid, a cellulose derivative such as hydroxypropyl cellulose, and an organic acid salt such as magnesium stearate. A gel-like substance or the like can be used as the carrier.
In a case where the coating composition is solid, the composition may be dissolved in a suitable dissolution solution and then used to coat at least one selected from a pearl nucleus or a mantle piece. For example, physiological saline, a variety of buffers, a solution of a saccharide such as glucose, inositol, mannitol, or lactose, or a glycol such as ethylene glycol or polyethylene glycol is preferable as the dissolution solution. In addition, the coating composition may be a freeze-dried product obtained by freeze-drying the protein of the present disclosure together with an activation agent, for example, a sugar such as inositol, mannitol, lactose, sucrose, or trehalose or an amino acid such as phenylalanine. The freeze-dried product may be dissolved in a suitable dissolution solution, for example, a liquid such as sterilized water, physiological saline, glucose solution, electrolyte solution, or amino acid solution at the time of use and then used for coating.
The coating composition may further contain one or more selected from a salt such as NaCl, a buffer such as HEPES or PBS, a thickener, a pH adjuster, a stabilizer, a light absorber, and the like. In addition, the coating composition may contain an antibiotic such as a penicillin-based antibiotic, a cephem-based antibiotic, a macrolide-based antibiotic, a tetracycline-based antibiotic, or a new quinolone-based antibiotic. The coating composition may contain a colorant, such as phenol red or eosin. The concentration of the protein of the present disclosure in the coating composition is, for example, 0.0001% by mass to 1% by mass, and may be 0.0005% by mass to 0.5% by mass.
Use of the coating composition of the present disclosure makes it possible to produce at least one selected from a pearl nucleus or a mantle piece, which improves the yield of a high quality pearl and is excellent in the operability of nucleus insertion into a mother pearl oyster. Examples [0038] Hereinafter, the present disclosure will be described more specifically with reference to
12316751_1 (GHMatters) P113238.AU
Examples, but the present invention is not limited to the following Examples as long as the gist of the present invention is not exceeded. Unless otherwise specified, “parts” and “%” are based on mass.
[0039] <Examples 1 to 3>
(Measurement of weight-average molecular weight (Mw), number-average molecular weight (Mn), and polydispersity (Mw/Mn) by gel permeation chromatography (GPC))
The weight-average molecular weight (Mw), number-average molecular weight (Mn), polydispersity (Mw/Mn), and viscosity of a cellnest human type I collagen-like recombinant peptide (manufactured by Fujifilm Corporation) were measured according to the following methods.
Here, the cellnest human type I collagen-like recombinant peptide has a structure in which a site containing an RGD sequence having high cell adhesiveness is cut out from human type I collagen al chain into four patterns of fragments which are then linked to each other, and the resulting three linked structures of four patterns of fragments are further linked. More specifically, the cellnest human type I collagen-like recombinant peptide has the amino acid sequence set forth in SEQ ID NO: 1, is made up of 571 amino acids in which the GXY triplet is repeated, and contains 12 RGD motifs.
[0040] The molecular weight of the cellnest human type I collagen-like recombinant peptide (manufactured by Fujifilm Corporation) was determined as a pullulan-converted molecular weight by the measurement using a GPC apparatus (HLC-8220GPC, manufactured by Tosoh Corporation) under the following conditions. An aqueous solution of a protein to be measured (after thawing for a frozen preparation) was heated at 40°C for 30 minutes to completely dissolve the protein, diluted with 100 mM phosphate buffer such that the concentration of the protein to be measured was 0.2% by mass, and then filtered through a 0.45 pm filter to prepare a sample solution. The weight-average molecular weight and the number-average molecular weight of the protein to be measured were determined by measuring the sample solution using the above GPC apparatus, and the polydispersity was further calculated from the obtained weight-average molecular weight and number-average molecular weight.
[GPC measurement conditions]
Column: Shodex Asahipak GS-620 7G-P, inner diameter: 7.5 mm, length: 50 cm (manufactured by Showa Denko K.K.)
Eluent: 100 mM phosphate buffer (pH = 6.9)
12316751_1 (GHMatters) P113238.AU
Flow rate: sample: 1.0 mL/min, reference: 0.1 mL/min
Column temperature (setting): 40°C
Injection volume: 100 pL
Detector: RI/UV (210 nm)
Protein for molecular weight calibration: pullulan (Shodex P-82, manufactured by Showa Denko K.K.) [0041] Table 1 shows the weight-average molecular weight (Mw), number-average molecular weight (Mn), and polydispersity (Mw/Mn) of the cellnest human type I collagen-like recombinant peptide determined as described above.
[0042] (Production of coated nucleus 1)
Water for injection (manufactured by Hikari Pharmaceutical Co., Ltd.) was added to 100 mg of the cellnest human type I collagen-like recombinant peptide (manufactured by Fujifilm Corporation, freeze-dried product), followed by mixing using a 300 ml Erlenmeyer flask (manufactured by AGC Techno Glass Co., Ltd.) to prepare a 0.1% coating aqueous solution 1. The cellnest human type I collagen-like recombinant peptide has the amino acid sequence of SEQ ID NO: 1.
[0043] An untreated nucleus (pearl nuclei) having a size of about 7 mm in diameter, which had been washed and sterilized, was completely immersed in the prepared coating aqueous solution 1 which was then shaken and stirred at 37°C for 2 hours. Then, the mixture was filtered through a metal colander (16 mesh), and then dried under an atmosphere of a temperature of 25°C and a humidity of 55% for 24 hours to produce a coated nucleus 1.
[0044] (Production of coated mantle piece 1)
An untreated, common pearl-forming mantle piece was completely immersed in the coating aqueous solution 1 prepared as described above at 25°C for 1 hour, and was taken out to prepare a coated mantle piece 1.
[0045] (Pearl culture experiment)
A group of 200 Pinctada fucata martensii mother pearl oysters (natural shellfishes, 2 years old) were prepared, and the nucleus insertion culture was carried out using coated nuclei 1 produced as described above and uncoated mantle pieces (Example 1), or coated mantles 1 and uncoated pearl nuclei (Example 2), and coated nuclei 1 and coated mantle pieces 1 (Example 3). The operability at the time of nucleus insertion, and the good quality pearl yield after extracting the nucleus from the shellfish eight months later, and the operability at the time of nucleus insertion were evaluated as follows.
12316751_1 (GHMatters) P113238.AU [0046] - Good quality pearl yield The presence or absence of a stain on the pearl surface and the area of the stain greatly affect the value of the pearl.
The good quality pearl yield was evaluated by using a percentage at which the stain area on the pearl surface was 0% or more and less than 5% (level of no stain to level at which slight stain was observed) as an evaluation index. Here, the stain is a generic term for abnormally deposited proteins that exist between the nucleus and the pearl layer or between the pearl layer and the pearl layer. The percentage of a brown to black colored area to a total surface area of the pearl was evaluated as the stain area. Specifically, the pearl was imaged with a digital camera from four directions, up, down, left, and right, and the stain area was calculated.
According to this evaluation index, the good quality pearl yield was determined according to the following evaluation standards. Note that the ratings of A and B are practically acceptable levels.
— Evaluation standards —
A: The percentage of the area of the stain being 0% or more and less than 5% is 40% or more.
B: The percentage of the area of the stain being 0% or more and less than 5% is 35% or more and less than 40%.
C: The percentage of the area of the stain being 0% or more and less than 5% is 30% or more and less than 35%.
D: The percentage of the area of the stain being 0% or more and less than 5% is 25% or more and less than 30%.
E: The percentage of the area of the stain being 0% or more and less than 5% is less than 25%.
[0047] - Operability at the time of nucleus insertion The efficiency of the operation of inserting a nucleus with an inserter at the time of nucleus insertion greatly affects the productivity of pearl culture.
The operability at the time of nucleus insertion was evaluated by a skilled operator of the nucleus insertion operation as to whether or not the operability of the inserter was good due to the tackiness (stickiness) of the nucleus at the time of nucleus insertion.
According to this evaluation index, the operability at the time of nucleus insertion was determined according to the following evaluation standards. Note that the rating of A is
12316751_1 (GHMatters) P113238.AU a practically acceptable level.
— Evaluation standards —
A: The operability was equivalent to the untreated nuclei.
B: The slight stickiness was felt as compared to the untreated nuclei, and therefore the operability was poor.
C: The clear stickiness was felt as compared to the untreated nuclei, and therefore the operability was extremely poor.
The evaluation results are shown in Table 1.
[0048] «Comparative Example 1>
The good quality pearl yield and the operability at the time of nucleus insertion were evaluated in the same manner as in Examples 1 to 3, except that uncoated pearl nuclei and mantle pieces were used.
The evaluation results are shown in Table 1.
[0049] «Comparative Example 2 to Comparative Example 4>
The weight-average molecular weight (Mw), number-average molecular weight (Mn), and polydispersity (Mw/Mn) were measured to evaluate the good quality pearl yield and the operability at the time of nucleus insertion, in the same manner as in Examples 1 to 3, except that the cellnest human type I collagen-like recombinant peptide was replaced with pig skin-derived type I collagen-PSILK (manufactured by NH Foods Ltd., pig skin collagen I solution).
The evaluation results are shown in Table 1.
[0050] Comparative Example 5 to Comparative Example 7>
The weight-average molecular weight (Mw), number-average molecular weight (Mn), and polydispersity (Mw/Mn) were measured to evaluate the good quality pearl yield and the operability at the time of nucleus insertion, in the same manner as in Examples 1 to 3, except that the cellnest human type I collagen-like recombinant peptide was replaced with high-grade gelatin-APAT (manufactured by Nippi, Inc.).
The evaluation results are shown in Table 1.
[0051] Comparative Example 8 to Comparative Example 10>
The weight-average molecular weight (Mw), number-average molecular weight (Mn), and polydispersity (Mw/Mn) were measured to evaluate the good quality pearl yield and the operability at the time of nucleus insertion, in the same manner as in Examples 1 to 3, except that the cellnest human type I collagen-like recombinant peptide was replaced with
12316751_1 (GHMatters) P113238.AU pig-derived collagen (manufactured by Nitta Gelatin Inc.).
The evaluation results are shown in Table 1.
[0052] Comparative Example 11 to Comparative Example 13>
The weight-average molecular weight (Mw), number-average molecular weight (Mn), and polydispersity (Mw/Mn) were measured to evaluate the good quality pearl yield and the operability at the time of nucleus insertion, in the same manner as in Examples 1 to 3, except that the cellnest human type I collagen-like recombinant peptide was replaced with pig-derived gelatin (manufactured by Nitta Gelatin Inc.).
The evaluation results are shown in Table 1.
[0053] Comparative Example 14 to Comparative Example 16>
The weight-average molecular weight (Mw), number-average molecular weight (Mn), and polydispersity (Mw/Mn) were measured to evaluate the good quality pearl yield and the operability at the time of nucleus insertion, in the same manner as in Examples 1 to 3, except that the cellnest human type I collagen-like recombinant peptide was replaced with bovine-derived gelatin (manufactured by Nitta Gelatin Inc.).
The evaluation results are shown in Table 1.
12316751_1 (GHMatters) P113238.AU [0054] [Table 1]
| Operability at the time of nucleus insertion | - | U | - | U | CQ | - | CQ | CQ | - | CQ | U | - | U | CQ | - | CQ | ||||
| Good quality pearl yield | <d | <d | U | U | U | U | U | U | U | U | U | CQ | U | CQ | U | U | U | w | ||
| Stain area in pearls [%] | 5% or more | CO in | in in | $ | $ | o | $ | o© | o© | m | o© | m | o© | $ | ||||||
| 0% or more and less than 5% | 9 | VD | CO | CO | £ | o | CCl | Γ4 | £ | Γ4 | £ | m | Γ4 | m | Γ4 | cn | cn | |||
| Polydispersity (Mw/Mn) | 287.78 | 95.56 | 2172.25 | 27.92 | 63.67 | |||||||||||||||
| Number-averag e molecular weight (Mn) [Da] | 48787 | 786 | 464 | un | 8135 | 4114 | ||||||||||||||
| Weight-average molecular weight (Mw) [Da] | 56494 | 226194 | 44342 | 121646 | 227094 | 261944 | ||||||||||||||
| Coating material | Cellnest human type I collagen-like recombinant peptide (manufactured by Fujifilm Corporation) | Pig skin-derived type I collagen-PSILK (manufactured by NH Foods Ltd.) | High-grade gelatin-APAT (manufactured by Nippi, Inc.) | Pig-derived collagen (manufactured by Nitta Gelatin Inc.) | Pig-derived gelatin (manufactured by Nitta Gelatin Inc.) | Bovine-derived gelatin (manufactured by Nitta Gelatin Inc.) | None | |||||||||||||
| Coated or uncoated | Mantle piece | Uncoated | Coated | Coated | Uncoated | Coated | Coated | Uncoated | Coated | Coated | Uncoated | Coated | Coated | Uncoated | Coated | Coated | Uncoated | Coated | Coated | Uncoated |
| Pearl nucleus | Coated | Uncoated | Coated | Coated | Uncoated | Coated | Coated | Uncoated | Coated | Coated | Uncoated | Coated | Coated | Uncoated | Coated | Coated | Uncoated | Coated | Uncoated | |
| | Example 1 | | Example 2 | | Example 3 | | Comparative Example 2 | | Comparative Example 3 | | Comparative Example 4 | | Comparative Example 5 | | Comparative Example 6 | | Comparative Example 7 | | Comparative Example 8 | | Comparative Example 9 | | Comparative Example 10 | | Comparative Example 11 | | Comparative Example 12 | | Comparative Example 13 | | Comparative Example 14 | | Comparative Example 15 | | Comparative Example 16 | | Comparative Example 1 |
12316751_1 (GHMatters) P113238.AU [0055] It was shown that the good quality pearl yield and the operability at the time of nucleus insertion were excellent in a case where the cellnest human type I collagen-like recombinant peptide having the amino acid sequence set forth in SEQ ID NO: 1, made up of 571 amino acids in which GXY triplets are repeated, containing 12 RGD motifs, and having a polydispersity of 1.16 was coated on the pearl nucleus, the mantle piece, or both the pearl nucleus and the mantle piece (Examples 1 to 3).
On the other hand, it was shown in Comparative Examples 1 to 16 that at least one of the good quality pearl yield or the operability at the time of nucleus insertion was at an evaluation level that was not practically acceptable.
[0056] The disclosure of JP2017-214180 filed on November 6, 2017 is incorporated herein by reference in its entirety.
All publications, patent applications, and technical standards mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent application, and technical standard were specifically and individually indicated to be incorporated by reference.
Industrial Applicability [0057] The pearl culture material of the present disclosure can be preferably used for producing a good quality pearl.
Claims (5)
- WHAT IS CLAIMED IS:1. A pearl culture material in which at least one selected from the group consisting of a pearl nucleus and a mantle piece is coated with a protein containing a repeating sequence of GXY triplets which may be separated by one or more amino acids, and one or more RGD motifs, and having a polydispersity of less than 20.
- 2. The pearl culture material according to claim 1, wherein the protein has a weight-average molecular weight of 30 kDa to 200 kDa determined by gel permeation chromatography.
- 3. The pearl culture material according to claim 1 or 2, wherein the protein comprises at least a part of an amino acid sequence of collagen.
- 4. The pearl culture material according to claim 3, wherein the amino acid sequence of the collagen is an amino acid sequence of type I collagen al.
- 5. A coating composition for coating at least one selected from a pearl nucleus or a mantle piece, comprising:a protein containing a repeating sequence of GXY triplets which may be separated by one or more amino acids, and one or more RGD motifs, and having a polydispersity of less than 20.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017214180 | 2017-11-06 | ||
| JP2017-214180 | 2017-11-06 | ||
| PCT/JP2018/036741 WO2019087650A1 (en) | 2017-11-06 | 2018-10-01 | Material for pearl culturing and coating composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2018360532A1 true AU2018360532A1 (en) | 2020-05-21 |
Family
ID=66333487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2018360532A Abandoned AU2018360532A1 (en) | 2017-11-06 | 2018-10-01 | Material for pearl culturing and coating composition |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20200296940A1 (en) |
| JP (1) | JPWO2019087650A1 (en) |
| KR (1) | KR102476632B1 (en) |
| AU (1) | AU2018360532A1 (en) |
| WO (1) | WO2019087650A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3864959A4 (en) * | 2018-10-12 | 2021-12-22 | FUJIFILM Corporation | Material for pearl culturing, nucleus-inserting method, and composition of material for pearl culturing |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01148135A (en) * | 1987-12-07 | 1989-06-09 | Matsushita Pearl Kk | Nucleus for pearl cultivation and pearl cultivation |
| JP3145454B2 (en) * | 1991-07-04 | 2001-03-12 | 寳酒造株式会社 | Cell activator for pearl culture |
| JPH07132032A (en) * | 1993-11-10 | 1995-05-23 | Koken Co Ltd | Method for treating pearl nucleus |
| AU3406800A (en) * | 2000-05-12 | 2001-11-22 | Koken Co., Ltd. | A coated nucleus for a cultured pearl |
| EP1845107B1 (en) | 2003-03-28 | 2019-05-29 | FUJIFILM Manufacturing Europe B.V. | Drug delivery system comprising RGD-enriched gelatine-like proteins with enhanced cell binding |
| WO2008103043A1 (en) * | 2007-02-21 | 2008-08-28 | Fujifilm Manufacturing Europe B.V. | Rgd containing recombinant gelatin |
| WO2016063935A1 (en) * | 2014-10-22 | 2016-04-28 | 富士フイルム株式会社 | Microcarrier adjustment method, microcarrier, and application thereof |
-
2018
- 2018-10-01 AU AU2018360532A patent/AU2018360532A1/en not_active Abandoned
- 2018-10-01 JP JP2019550907A patent/JPWO2019087650A1/en not_active Abandoned
- 2018-10-01 WO PCT/JP2018/036741 patent/WO2019087650A1/en active Application Filing
- 2018-10-01 KR KR1020207012850A patent/KR102476632B1/en active IP Right Grant
-
2020
- 2020-04-30 US US16/862,590 patent/US20200296940A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20200296940A1 (en) | 2020-09-24 |
| KR20200060497A (en) | 2020-05-29 |
| KR102476632B1 (en) | 2022-12-09 |
| WO2019087650A1 (en) | 2019-05-09 |
| JPWO2019087650A1 (en) | 2020-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Varshney et al. | Soy protein isolate supplemented silk fibroin nanofibers for skin tissue regeneration: Fabrication and characterization | |
| Song et al. | Collagen scaffolds derived from a marine source and their biocompatibility | |
| Rosellini et al. | Preparation and characterization of alginate/gelatin blend films for cardiac tissue engineering | |
| Lutz et al. | Bio-based and bio-inspired adhesives from animals and plants for biomedical applications | |
| El Blidi et al. | Extraction methods, characterization and biomedical applications of collagen: A review | |
| Zhao et al. | Enzymatic degradation of Antheraea pernyi silk fibroin 3D scaffolds and fibers | |
| JP5870398B2 (en) | High strength collagen fiber membrane and method for producing the same | |
| CN105985529B (en) | Sericin-alginate composite hydrogel and preparation method thereof | |
| Thakur et al. | Crosslinking biopolymers for advanced drug delivery and tissue engineering applications | |
| US20100190704A1 (en) | Structure comprising chitosan and collagen | |
| Park et al. | Comparative analysis of collagens extracted from different animal sources for application of cartilage tissue engineering | |
| US20240165299A1 (en) | Tissue scaffold | |
| JP2006257013A (en) | Collagen gel derived from scale and method for preparing the same gel | |
| Wang et al. | Accelerating effects of genipin-crosslinked small intestinal submucosa for defected gastric mucosa repair | |
| US20200296940A1 (en) | Pearl culture material and coating composition | |
| Lin et al. | Studies of novel hyaluronic acid-collagen sponge materials composed of two different species of type I collagen | |
| US20140220688A1 (en) | Thermally Induced Gelation Of Collagen Hydrogel And Method Of Thermally Inducing Gelling A Collagen Hydrogel | |
| KR102182882B1 (en) | Porcine Dermis-derived Barrier Membrane for Dental Applications and Method for Fabricating the Same | |
| AU2019358933B2 (en) | Pearl culture material, nucleus insertion method, and pearl culture material composition | |
| JP2014166217A (en) | Collagen fiber inorganic polymer composite and method for producing the same | |
| CN107921173B (en) | Cell structure, non-human model animal, method for producing non-human model animal, and method for evaluating test substance | |
| KR102182883B1 (en) | Collagen Membrane and Method for Fabricating the Same | |
| KR20190134888A (en) | Sea Anemone-derived Silk Protein-Based Bioink for 3D Bioprinting and Uses Thereof | |
| US20210324045A1 (en) | Bullfrog skin-derived collagen, materials comprising thereof, and applications in wound healing | |
| Nair | Biodegradable hydrogels from silk sericin & Gelatin: development and characterization for medical applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |